Share to

Overview

Specs

Technical Documents

Articles

reviews

Consult

returns

Product introduction

Laprituximab (J2898A) is a humanized IgG1 anti- EGFR antibody that can be used for the synthesis of ADC IMGN289. In Vivo In the H292 xenograft tumor model, the minimally effective doses of Laprituximab (J2898A) is 3 mg/kg . MCE has not independently confirmed the accuracy of these methods. They are for reference only. Form:Liquid

Specs ⸢ View details ⸥

Chinese name

Laprituximab

English name

Laprituximab

Chinese alias

拉普妥昔单抗

English alias

CAS number

1622327-38-1

molecular formula

molecular weight

Exact mass

≥95%

PSA

Logp

Technical Documents

「No technical documents」

「No upstream and downstream information yet」

Articles

「No related articles yet」

user reviews

Consultation

Warm reminder：

Because the manufacturer may temporarily adjust product specifications, prices, inventory, parameters and other information without notice, and there are differences in each user's consultation time and procurement needs, the platform reply content is only of reference value within a certain period. Sorry for the inconvenience caused to you, and thank you for your understanding and support! Please consult the online customer service for the latest details. Everything is subject to the real-time reply of the customer service.！

After Sales Services

Please check the quantity, appearance and product information in time when you receive the goods. In case of damage, wrong delivery, abnormal quality and other problems, please feel free to contact us.

Service Hotline:400-6226-992 ，We will handle it for you as soon as possible, thank you for your support and trust.！